ACE Inhibitors

What it is

ACE inhibitors are medicines first approved in 1981 that lower blood pressure and protect the heart and kidneys by blocking angiotensin-converting enzyme. They are also called angiotensin-converting enzyme inhibitors or ACEi. This drug class is widely used for hypertension, heart failure with reduced ejection fraction, after some heart attacks, and in selected people with chronic kidney disease, especially when albuminuria is present.

ACE inhibitors work on the renin-angiotensin-aldosterone system, a hormone system that helps regulate blood pressure, salt balance, and blood vessel tone. Common examples include enalapril, lisinopril, ramipril, captopril, perindopril, benazepril, fosinopril, quinapril, moexipril, and trandolapril. In India, these medicines are commonly prescribed for hypertension and diabetic kidney disease, but the exact choice depends on kidney function, potassium level, pregnancy status, and whether a person develops cough or angioedema.

Common ACE inhibitors	Notes
Captopril	Shorter acting; first ACE inhibitor approved in 1981
Enalapril	Commonly used for hypertension and heart failure
Lisinopril	Common once-daily option in many settings
Ramipril	Often used in cardiovascular risk reduction
Perindopril	Used for hypertension and some heart disease settings

How it works

ACE inhibitors block the conversion of angiotensin I to angiotensin II. Angiotensin II normally narrows blood vessels and stimulates aldosterone release, which increases sodium and water retention. By reducing angiotensin II, ACE inhibitors relax blood vessels, lower blood pressure, and reduce the workload on the heart.

They also reduce aldosterone, which can lower fluid retention and help in heart failure. Another effect is reduced breakdown of bradykinin. This may contribute to blood vessel relaxation, but it also explains why ACE inhibitors can cause a dry cough and, rarely, angioedema.

In the kidneys, ACE inhibitors lower pressure inside the glomeruli, the filtering units. That is one reason they can slow progression of some forms of chronic kidney disease, particularly when protein or albumin is leaking into the urine. A small rise in serum creatinine can occur after starting treatment because kidney blood flow dynamics change; this is often monitored rather than treated as an automatic reason to stop the drug.

Evidence and uses

ACE inhibitors are established, evidence-based drugs for several cardiovascular and kidney conditions. Major guideline-supported uses include:

1. Hypertension: They are one of the standard first-line drug classes for many adults with high blood pressure.
2. Heart failure with reduced ejection fraction: They improve symptoms and reduce hospitalization and death risk in appropriate patients.
3. After myocardial infarction: They are often used after a heart attack, especially when left ventricular dysfunction is present.
4. Chronic kidney disease with albuminuria: They can slow kidney damage progression, especially in diabetes.

For uncomplicated hypertension, ACE inhibitors lower blood pressure effectively, but they are not always the best fit for every patient. Comparative research suggests ACE inhibitors and angiotensin receptor blockers, or ARBs, have broadly similar effectiveness for first-line blood pressure treatment, while ARBs may cause fewer side effects such as cough and angioedema. That is why some people who cannot tolerate an ACE inhibitor are switched to an ARB.

ACE inhibitors are not interchangeable with every blood pressure medicine. For example, calcium channel blockers or thiazide-type diuretics may be preferred in some patients based on age, race, edema risk, kidney function, or other conditions. In people with diabetes, chronic kidney disease, or heart failure, ACE inhibitors often have a stronger role because of kidney and heart protection beyond blood pressure lowering alone.

In India, hypertension and diabetes are both common, so ACE inhibitors are frequently used in routine practice. Indian clinicians also consider local patterns such as high salt intake, variable access to lab monitoring, and the need for affordable generics. Still, treatment should follow a clinician's assessment rather than self-medication.

Safety and interactions

ACE inhibitors can be very helpful, but they need monitoring.

Common and important adverse effects include:

Safety issue	Why it matters
Dry cough	Often persistent; related to bradykinin
High potassium	Can become dangerous, especially with kidney disease
Rise in creatinine	May be expected early, but needs monitoring
Low blood pressure	More likely after the first doses or with dehydration
Angioedema	Rare but potentially life-threatening swelling of face, lips, or airway

ACE inhibitors should not be used during pregnancy because they can harm the fetus. They are also generally avoided in people with a history of ACE inhibitor-related angioedema. Caution is needed in bilateral renal artery stenosis, advanced kidney impairment, dehydration, or when starting treatment in someone already taking strong diuretics.

Important interactions include potassium supplements, salt substitutes containing potassium, potassium-sparing diuretics such as spironolactone, trimethoprim, and some other medicines that raise potassium. Nonsteroidal anti-inflammatory drugs, or NSAIDs, can reduce kidney blood flow and increase the risk of kidney injury, especially when combined with an ACE inhibitor and a diuretic. Combining an ACE inhibitor with an ARB or with aliskiren is generally avoided because it increases adverse effects without clear added benefit in most patients.

People starting an ACE inhibitor usually need blood tests for serum creatinine and potassium soon after initiation or dose increase. Do not stop or restart the medicine on your own unless a clinician has advised it. If you develop facial swelling, trouble breathing, fainting, or severe weakness, seek urgent care.

When to see a clinician

See a clinician if you have high blood pressure readings, swelling, shortness of breath, diabetes with kidney disease, or a history of heart attack or heart failure and want to know whether an ACE inhibitor is appropriate. You should also seek review if you develop a persistent dry cough after starting one of these medicines.

Urgent evaluation is needed for swelling of the lips, tongue, or throat; severe dizziness; very low urine output; or symptoms that suggest high potassium, such as marked weakness or palpitations. Routine follow-up matters because blood pressure, kidney function, and potassium should be checked after starting treatment and periodically afterward.

Limitations and open questions

ACE inhibitors are a core drug class, but they are not ideal for everyone. Some people cannot tolerate cough, and rare angioedema can be serious. In many patients with uncomplicated hypertension, ARBs may offer similar blood pressure and cardiovascular benefit with fewer side effects.

Evidence is strong for major uses such as hypertension, heart failure with reduced ejection fraction, and kidney disease with albuminuria. But the best first-line choice still depends on the individual patient's age, comorbidities, baseline kidney function, concurrent medicines, and ability to complete lab monitoring. Research continues on which patients benefit most from ACE inhibitors versus ARBs and how to personalize treatment while minimizing kidney and potassium-related complications.